No paralogue variants have been mapped to residue 65 for KCNQ1.
KCNQ1 | -A--GGALYAPIAPGAPGP--------APP>A<SPAAPAAPPVASDL---GPRPPVSL----- | 87 |
KCNQ2 | -------------A-PK------------->-<-RGSILS----------KPRAGG--AGAGK | 66 |
KCNQ3 | -----------------DEG-----QR--->R<----TPQ----------GIGL-LAKTPLSR | 95 |
KCNQ4 | -----------RRLGLLGSP-----L---->-<-PPGAPLP---------GPGSGSGSACGQR | 72 |
KCNQ5 | -----------ATLGGGGGG-----LRESR>R<GKQGARMS---------LLGKPL-SYTSSQ | 100 |
KCNA1 | FDPLRNEYFFDRNRPSFDAILYYYQSGGRL>R<RPVNVPLDMFSEEIKFYELGEEAME----K | 129 |
KCNA10 | FDSMRNEYFFDRNRPSFDGILYYYQSGGKI>R<RPANVPIDIFADEISFYELGSEAMD----Q | 178 |
KCNA2 | FDPLRNEYFFDRNRPSFDAILYYYQSGGRL>R<RPVNVPLDIFSEEIRFYELGEEAME----M | 125 |
KCNA3 | FDPLRNEYFFDRNRPSFDAILYYYQSGGRI>R<RPVNVPIDIFSEEIRFYQLGEEAME----K | 196 |
KCNA4 | FDPLRNEYFFDRNRPSFDAILYYYQSGGRL>K<RPVNVPFDIFTEEVKFYQLGEEALL----K | 268 |
KCNA5 | FDPLRNEYFFDRNRPSFDGILYYYQSGGRL>R<RPVNVSLDVFADEIRFYQLGDEAME----R | 212 |
KCNA6 | FDPLRNEYFFDRNRPSFDAILYYYQSGGRL>R<RPVNVPLDIFLEEIRFYQLGDEALA----A | 133 |
KCNA7 | YDDARREYFFDRHRPSFDAVLYYYQSGGRL>R<RPAHVPLDVFLEEVAFYGLGAAALA----R | 105 |
KCNB1 | YSLDDNEYFFDRHPGAFTSILNFYRT-GRL>H<MMEEMCALSFSQELDYWGIDEIYLE----S | 131 |
KCNB2 | YNLNENEYFFDRHPGAFTSILNFYRT-GKL>H<MMEEMCALSFGQELDYWGIDEIYLE----S | 135 |
KCNC1 | YDPRADEFFFDRHPGVFAHILNYYRT-GKL>H<CPADVCGPLYEEELAFWGIDETDVE----P | 103 |
KCNC2 | HPGGGREFFFDRHPGVFAYVLNYYRT-GKL>H<CPADVCGPLFEEELAFWGIDETDVE----P | 150 |
KCNC3 | YDPGADEFFFDRHPGVFAYVLNYYRT-GKL>H<CPADVCGPLFEEELGFWGIDETDVE----A | 183 |
KCNC4 | SGGGGCEFFFDRHPGVFAYVLNYYRT-GKL>H<CPADVCGPLFEEELTFWGIDETDVE----P | 142 |
KCND1 | YDADSGEYFFDRDPDMFRHVLNFYRT-GRL>H<CPRQECIQAFDEELAFYGLVPELVG----D | 130 |
KCND2 | YHPETQQYFFDRDPDIFRHILNFYRT-GKL>H<YPRHECISAYDEELAFFGLIPEIIG----D | 131 |
KCND3 | FNEDTKEYFFDRDPEVFRCVLNFYRT-GKL>H<YPRYECISAYDDELAFYGILPEIIG----D | 130 |
KCNF1 | YDPGKREFYFDRDPDAFKCVIEVYYF-GEV>H<MKKGICPICFKNEMDFWKVDLKFLD----D | 125 |
KCNG1 | YDVTCNEFFFDRNPGAFGTILTFLRA-GKL>R<LLREMCALSFQEELLYWGIAEDHLD----G | 163 |
KCNG2 | YDVSRDEFFFDRSPCAFRAIVALLRA-GKL>R<LLRGPCALAFRDELAYWGIDEARLE----R | 117 |
KCNG3 | YDRERNEYFFDRHSEAFGFILLYVRGHGKL>R<FAPRMCELSFYNEMIYWGLEGAHLE----Y | 110 |
KCNG4 | YDEDSQEFFFDRSPSAFGVIVSFLAA-GKL>V<LLQEMCALSFQEELAYWGIEEAHLE----R | 159 |
KCNS1 | YDEAAREFYFDRHPGFFLSLLHFYRT-GHL>H<VLDELCVFAFGQEADYWGLGENALA----A | 150 |
KCNS2 | YDDVQREFYFDRNPELFPYVLHFYHT-GKL>H<VMAELCVFSFSQEIEYWGINEFFID----S | 117 |
KCNS3 | YSVADKEYYFDRNPSLFRYVLNFYYT-GKL>H<VMEELCVFSFCQEIEYWGINELFID----S | 115 |
KCNV1 | ANPVDNEYFFDRSSQAFRYVLHYYRT-GRL>H<VMEQLCALSFLQEIQYWGIDELSID----S | 149 |
KCNV2 | YEEQTDEYFFDRDPAVFQLVYNFYLS-GVL>L<VLDGLCPRRFLEELGYWGVRLKYTP----R | 197 |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.A65V | c.194C>T | Putative Benign | rs2522019 | SIFT: tolerated Polyphen: benign |